1. Moar P, Linn K, Premeaux TA, Bowler S, et al.
   Plasma Galectin-9 relates to cognitive performance and inflammation among adolescents with vertically acquired HIV.
   AIDS 2024.
   


2. Flores JM, Moline T, Regan SD, Chen YT, et al.
   Neighborhood violent crime exposure is associated with PrEP non-use among black sexually minoritized men and transgender women: A GPS Study.
   AIDS 2024.
   


3. Jang Y, Kim T, Choi Y, Ahn KH, et al.
   Association between obesity and cancer risk in HIV-infected Asians.
   AIDS 2024.
   


4. Oosterhof P, Van Luin M, Brinkman K, Burger DM, et al.
   Negative impact of a health insurer-mandated de-simplification from a single-tablet regimen to a two-tablet regimen.
   AIDS 2024.
   


5. Guaraldi G, Milic J, Renzetti S, Motta F, et al.
   The effect of weight gain and metabolic dysfunction-associated steatotic liver disease on liver fibrosis progression and regression in people with HIV.
   AIDS 2024.
   


6. Salto JN, Volkow P, Herrera-Goepfert R, Lopez-Garcia AI, et al.
   Unmasked Kaposi and sarcoidosis immune reconstitution inflammatory syndrome in a patient with AIDS.
   AIDS 2024;38:933-934.
   


7. Libman H, Krakower D, Taylor JL, Burns RB, et al.
   How Would You Manage HIV Pre-exposure Prophylaxis in This Patient With Medical Comorbidities? : Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
   Ann Intern Med 2024.
   


8. Wohl DA, Koethe JR, Sax PE, McComsey GA, et al.
   Antiretrovirals and Weight Change: Weighing the Evidence.
   Clin Infect Dis 2024.
   


9. Damas J, Munting A, Fellay J, Haerry D, et al.
   Weight, anthropometric and metabolic changes after discontinuing antiretroviral therapy containing tenofovir alafenamide (TAF) in people with HIV.
   Clin Infect Dis 2024.
   


10. Sherman A, Tuan J, Cantos VD, Adeyiga O, et al.
    COVID-19 vaccine efficacy in participants with weakened immune systems from four randomized-controlled trials.
    Clin Infect Dis 2024.
    


11. Chabala C, Wobudeya E, van der Zalm MM, Kapasa M, et al.
    Clinical outcomes in children living with HIV treated for non-severe tuberculosis in the SHINE Trial.
    Clin Infect Dis 2024.
    


12. .
    Time to Treatment Initiation and HIV Viral Suppression in People Diagnosed With HIV-1 During COVID-19 Pandemic in Ex-Aquitaine, France (ANRS CO3 AQUIVIH-NA Cohort-QuAliCOV Study): Erratum.
    J Acquir Immune Defic Syndr 2024;96:e3.
    


13. Rambiki E, Rambiki K, Khalani J, Huwa J, et al.
    Letters to the Editor Low Rates of Side Effects in Paclitaxel Chemotherapy for Kaposi Sarcoma and Feasibility of Treatment in Outpatient ART Clinic Settings in Malawi.
    J Acquir Immune Defic Syndr 2024;96:e1-e2.
    


14. .
    Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
    Lancet 2024.
    

Display articles in

• Abstract format
• Medline format